• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    71 Biggest Movers From Yesterday

    5/20/22 4:27:31 AM ET
    $ACRX
    $AFI
    $APCX
    $AUUD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Building Products
    Capital Goods
    Get the next $ACRX alert in real time by email

    Gainers

    • NeuroMetrix, Inc. (NASDAQ:NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.
    • VivoPower International PLC (NASDAQ:VVPR) gained 46.3% to close at $1.58.
    • NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) surged 29.6% to close at $0.7905. The FDA recently reviewed NeuroOne Medical Technologies appeal for 510(k) clearance for its Evo sEEG Electrode for less than 30-day use.
    • BIT Mining Limited (NYSE:BTCM) rose 28.1% to settle at $2.10.
    • Pop Culture Group Co., Ltd (NASDAQ:CPOP) gained 27.6% to close at $1.11. Pop Culture recently posted Q1 sales of $20.15 million.
    • AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) surged 27.6% to settle at $0.2892. The FDA has recently modified the AcelRx Pharmaceuticals Dsuvia Risk Evaluation and Mitigation Strategies (REMS) requirements for healthcare setting audits.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) jumped 25.4% to close at $1.63.
    • Celyad Oncology SA (NASDAQ:CYAD) gained 25% to close at $1.9250.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) jumped 25% to settle at $13.60.
    • Pineapple Energy Inc. (NASDAQ:PEGY) gained 24.2% to close at $2.72.
    • Grab Holdings Limited (NASDAQ:GRAB) rose 24.1% to settle at $3.14 after reporting Q1 results.
    • IMAC Holdings, Inc. (NASDAQ:IMAC) gained 22.3% to close at $1.04. IMAC Holdings’ 13G Filing from Notable Investor Peter Lynch showed a new 5.23% stake in the company.
    • Applied Blockchain, Inc. (NASDAQ:APLD) jumped 21.7% to close at $3.09.
    • Chimerix, Inc. (NASDAQ:CMRX) gained 21.6% to close at $2.20. Emergent BioSolutions recently agreed to acquire Chimerix exclusive worldwide rights to Tembexa (brincidofovir), the first FDA-approved antiviral for all age groups for smallpox.
    • Austin Gold Corp. (NYSE:AUST) rose 21.1% to settle at $2.07.
    • Troika Media Group, Inc. (NASDAQ:TRKA) gained 20.9% to close at $0.6990.
    • NanoViricides, Inc. (NYSE:NNVC) surged 20.9% to close at $1.85.
    • Iris Energy Limited (NYSE:IREN) gained 20.4% to close at $6.74.
    • Cellectis S.A. (NASDAQ:CLLS) surged 20.2% to close at $3.93.
    • AppTech Payments Corp. (NASDAQ:APCX) gained 20% to settle at $0.7657.
    • Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) rose 18.9% to close at $0.3491. Eloxx Pharmaceuticals recently reported quarterly losses of $0.13 per share.
    • Biotricity, Inc. (NASDAQ:BTCY) gained 18.8% to settle at $1.33.
    • Indaptus Therapeutics, Inc. (NASDAQ:INDP) surged 18.8% to settle at $2.97. The U.S. Food and Drug Administration (FDA) has announced clearance to Indaptus Therapeutics’ Investigational New Drug (IND) application for a Phase 1 clinical trial of its drug candidate Decoy20 in patients with advanced solid tumors where currently approved therapies have failed.
    • Staffing 360 Solutions, Inc. (NASDAQ:STAF) jumped 18.1% to close at $0.7523.
    • Immunome, Inc. (NASDAQ:IMNM) climbed 18% to close at $3.35 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of SARS-CoV-2 when tested in vivo in hamsters.
    • Zealand Pharma A/S (NASDAQ:ZEAL) climbed 17.9% to close at $13.79 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenital hyperinsulinism met the primary endpoint with statistical significance.
    • Eve Holding, Inc. (NYSE:EVEX) surged 17.7% to close at $8.35.
    • Nano-X Imaging Ltd. (NASDAQ:NNOX) gained 17.7% to close at $11.12. Nanox reported Q1 earnings results.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) shares rose 17.1% to close at $8.65 after the company announced the FDA approved the intravenous formulation of TPOXX for the treatment of smallpox.
    • Aclarion, Inc. (NASDAQ:ACON) gained 16.7% to close at $1.75.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) climbed 16.5% to close at $3.81 after the company reported results from its first drill tests from the Grass River Pegmatite dyke. The company also said its exploration permits have been extended by the Province of Manitoba for 3 years.
    • Sprout Social, Inc. (NASDAQ:SPT) rose 16.1% to close at $48.07.
    • Sweetgreen, Inc. (NYSE:SG) climbed 15.9% to close at $22.23.
    • GDS Holdings Limited (NASDAQ:GDS) climbed 14.5% to settle at $31.09. GDS Holdings posted a Q1 net loss of $58.9 million.
    • Bill.com Holdings, Inc. (NASDAQ:BILL) rose 12.6% to close at $114.42.
    • Novan, Inc. (NASDAQ:NOVN) gained 12.3% to settle at $2.92. Novan will present Berdazimer Gel, 10.3% (SB206) clinical data at Annual Meeting of the Society for Investigative Dermatology.
    • Kodiak Sciences Inc. (NASDAQ:KOD) rose 11.8% to settle at $6.71 after company director Felix Baker reported the purchase of 456,690 shares at an average price of $5.91 per share in a Form 4 filing on Wednesday.
    • Emergent BioSolutions Inc. (NYSE:EBS) rose 11.8% to close at $31.69.
    • Humanigen, Inc. (NASDAQ:HGEN) gained 10.3% to close at $2.24. Humanigen recently posted Q1 loss of $0.32 per share.
    • Synopsys, Inc. (NASDAQ:SNPS) surged 10.3% to close at $300.52 after the company reported better-than-expected Q2 results. The company also issued Q3 and FY22 EPS and sales guidance above analyst estimates.
    • Unity Software Inc. (NYSE:U) rose 10.2% to close at $41.65.
    • Chinook Therapeutics, Inc. (NASDAQ:KDNY) rose 10% to close at $13.85 as the company announced updated interim results from the Phase 1/2 study of BION-1301 in IgA nephropathy (IgAN).
    • Datadog, Inc. (NASDAQ:DDOG) rose 9.6% to close at $96.53.
    • Blend Labs, Inc. (NYSE:BLND) rose 6.7% to close at $3.53.

     

    Losers

    • Bright Green Corporation (NASDAQ:BGXX) shares tumbled 67.4% to close at $15.70 on Thursday after jumping 90% on Wednesday. Bright Green, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) fell 39% to close at $3.05 on Thursday.
    • Molecular Data Inc. (NASDAQ:MKD) dipped 27.5% to close at $0.1007. Molecular Data said on May 17 it received delinquency compliance plan alert letter from NASDAQ.
    • Prenetics Holding Company Limited (NASDAQ:PRE) fell 26.4% to close at $5.63.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 21.4% to close at $0.2548. Enjoy Technology recently reported worse-than-expected Q1 EPS and sales results.
    • Triumph Group, Inc. (NYSE:TGI) tumbled 20.4% to settle at $14.25 as Baird lowered the price target on the stock from $36 to $26. Triumph Group, on Wednesday, reported worse-than-expected Q4 EPS and sales results.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) fell 17.9% to close at $5.25.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 17.4% to close at $1.90. China SXT Pharmaceuticals reported a 1 for 20 reverse share split.
    • Auddia Inc. (NASDAQ:AUUD) declined 17.1% to settle at $0.9293.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) dropped 16.9% to close at $1.18.
    • Under Armour, Inc. (NYSE:UA) fell 15.8% to close at $8.18 after Morgan Stanley and Williams Capital downgraded the stock. Under Armour announced Wednesday that CEO Patrik Frisk is stepping down from his role of CEO, president and as a member of the Board of Directors.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) declined 14.8% to close at $3.05.
    • Mercurity Fintech Holding Inc. (NYSE:MFH) dropped 14.7% to close at $1.22.
    • Decisionpoint Systems, Inc. (NYSE:DPSI) fell 14.4% to close at $6.98.
    • Kidpik Corp. (NASDAQ:PIK) dropped 14.1% to close at $1.89.
    • Cisco Systems, Inc. (NASDAQ:CSCO) dipped 13.7% to close at $41.72. Cisco reported upbeat earnings for its third quarter, while sales missed estimates. The company also issued weak Q4 and FY22 earnings guidance.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) fell 13.4% to close at $5.62.
    • View, Inc. (NASDAQ:VIEW) dropped 13.1% to close at $0.6494.
    • Armstrong Flooring, Inc. (NYSE:AFI) fell 11.9% to close at $0.3787. Armstrong Flooring shares jumped 46% on Wednesday after receiving approval for additional financing.
    • OTR Acquisition Corp. (NASDAQ:OTRA) fell 11.8% to close at $9.91.
    • Conifer Holdings, Inc. (NASDAQ:CNFR) declined 11.4% to settle at $1.48.
    • Fresh Vine Wine, Inc. (NYSE:VINE) dipped 10.8% to close at $3.05. Fresh Vine Wine recently posted a Q1 loss of $0.35 per share.
    • Harley-Davidson, Inc. (NYSE:HOG) dropped 9.3% to close at $32.43. Harley-Davidson said certain vehicle assembly, shipments suspended for 2-week period, excluding livewire production.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) fell 9.1% to close at $0.1972 after climbing over 20% on Wednesday. Salarius Pharmaceuticals recently posted a Q1 loss of $0.13 per share.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 8.9% to close at $2.78 after gaining around 7% on Wednesday.
    • Monro, Inc. (NASDAQ:MNRO) fell 8.8% to close at $39.80 as the company posted Q4 results and announced a $150 million buyback. American Tire Distributors announced plans to acquire Monro's Tires Now distribution assets for $105 million in cash.
    • Bath & Body Works, Inc. (NYSE:BBWI) fell 6.8% to close at $40.03 after the company cut its FY22 EPS guidance below analyst estimates.
    Get the next $ACRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRX
    $AFI
    $APCX
    $AUUD

    CompanyDatePrice TargetRatingAnalyst
    Datadog Inc.
    $DDOG
    4/23/2026$170.00Buy
    Rothschild & Co Redburn
    Datadog Inc.
    $DDOG
    4/9/2026$175.00Neutral → Buy
    Guggenheim
    Cisco Systems Inc.
    $CSCO
    3/31/2026$94.00Buy
    Truist
    Sweetgreen Inc.
    $SG
    3/30/2026$4.50Mkt Underperform
    Citizens
    Immix Biopharma Inc.
    $IMMX
    3/25/2026$20.00Overweight
    Morgan Stanley
    Prenetics Global Limited
    $PRE
    3/16/2026$29.00Buy
    Lake Street
    Harley-Davidson Inc.
    $HOG
    3/11/2026$15.00Underweight
    Wells Fargo
    Sweetgreen Inc.
    $SG
    3/9/2026Peer Perform
    Wolfe Research
    More analyst ratings

    $ACRX
    $AFI
    $APCX
    $AUUD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Datadog with a new price target

    Rothschild & Co Redburn initiated coverage of Datadog with a rating of Buy and set a new price target of $170.00

    4/23/26 7:55:35 AM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    Datadog upgraded by Guggenheim with a new price target

    Guggenheim upgraded Datadog from Neutral to Buy and set a new price target of $175.00

    4/9/26 8:22:11 AM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    Truist initiated coverage on Cisco with a new price target

    Truist initiated coverage of Cisco with a rating of Buy and set a new price target of $94.00

    3/31/26 8:10:04 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $ACRX
    $AFI
    $APCX
    $AUUD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bienaime Jean Jacques bought $43,670 worth of shares (2,000 units at $21.84), increasing direct ownership by 5% to 38,415 units (SEC Form 4)

    4 - Immunome Inc. (0001472012) (Issuer)

    3/12/26 6:05:05 AM ET
    $IMNM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Urban David bought $100,100 worth of shares (16,250 units at $6.16), increasing direct ownership by 35% to 62,471 units (SEC Form 4)

    4 - Eos Energy Enterprises, Inc. (0001805077) (Issuer)

    3/10/26 8:52:43 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Chief Concept Officer Jammet Nicolas bought $25,284 worth of shares (4,428 units at $5.71) (SEC Form 4)

    4 - Sweetgreen, Inc. (0001477815) (Issuer)

    3/9/26 5:55:54 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    $ACRX
    $AFI
    $APCX
    $AUUD
    SEC Filings

    View All

    SEC Form EFFECT filed by Auddia Inc.

    EFFECT - AUDDIA INC. (0001554818) (Filer)

    4/24/26 12:15:15 AM ET
    $AUUD
    EDP Services
    Technology

    SEC Form 6-K filed by Alpha Tau Medical Ltd.

    6-K - Alpha Tau Medical Ltd. (0001871321) (Filer)

    4/23/26 9:02:03 AM ET
    $DRTS
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by Sweetgreen Inc.

    DEFA14A - Sweetgreen, Inc. (0001477815) (Filer)

    4/23/26 8:39:33 AM ET
    $SG
    Restaurants
    Consumer Discretionary

    $ACRX
    $AFI
    $APCX
    $AUUD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Officer Le-Quoc Alexis converted options into 43,224 shares and sold $5,655,316 worth of shares (43,224 units at $130.84) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Datadog, Inc. (0001561550) (Issuer)

    4/23/26 5:16:34 PM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Agarwal Amit

    4 - Datadog, Inc. (0001561550) (Issuer)

    4/22/26 4:04:00 PM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Huang Manxin

    3 - Pop Culture Group Co., Ltd (0001807389) (Issuer)

    4/21/26 4:00:23 PM ET
    $CPOP
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ACRX
    $AFI
    $APCX
    $AUUD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Auddia Announces Pricing of $12 Million Public Offering

    BOULDER, Colo., April 24, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), a technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced the pricing of a best efforts public offering of an aggregate of 5,084,745 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,084,745 shares of common stock (the "Warrants"), at a combined public offering price of $2.36 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $2.36

    4/24/26 9:15:00 AM ET
    $AUUD
    EDP Services
    Technology

    UNDER ARMOUR ANNOUNCES DATE FOR FOURTH QUARTER AND FULL-YEAR FISCAL 2026 EARNINGS CONFERENCE CALL

    BALTIMORE, April 23, 2026 /PRNewswire/ -- Under Armour, Inc. (NYSE:UA, UAA)) today announced that it will release its fourth quarter and full-year fiscal 2026 financial results, for the period ended March 31, 2026, on May 12, 2026. Following the earnings release, which will be issued at approximately 6:55 a.m. Eastern Time (ET), Under Armour management will host a conference call at approximately 8:30 a.m. ET to discuss the company's results.The conference call will be webcast live and available for replay on Under Armour's Investor Relations website at: https://about.underarmou

    4/23/26 4:30:00 PM ET
    $UA
    $UAA
    Apparel
    Consumer Discretionary

    Eos Energy Enterprises Announces Date for First Quarter 2026 Financial Results and Conference Call; Announces Participation at Upcoming Investor Conferences

    EDISON, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company"), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced it will release its first quarter 2026 financial results before the U.S. market opens on May 13, 2026. A conference call to discuss its results will take place the same morning at 8:30 a.m. Eastern Time. Eos partners with Say Technologies to allow retail and institutional shareholders to submit and vote on questions ahead of the earnings call. A selection of key question

    4/23/26 4:30:00 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $ACRX
    $AFI
    $APCX
    $AUUD
    Leadership Updates

    Live Leadership Updates

    View All

    Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations

    Press release – No. 7 / 2026    Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant experience from Vertex Pharmaceuticals and Shire Copenhagen, Denmark and Boston, Massachusetts, April 14, 2026 - Zealand Pharma A/S (NASDAQ:ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announced the appointment of Eric Rojas, Vice President, Investor Relations, effective April 15, 2026. Eric will report to Henriette Wennicke, Chief Financial Officer, and will be based in Massachusetts, U.S. Eric brings more than two decades of experience in investor relations and finance, having supported both US

    4/14/26 10:00:00 AM ET
    $ZEAL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HARLEY-DAVIDSON LAUNCHES RIDE

    A New Global Brand Platform Sets Stage For a New Era of Harley-Davidson, While Honoring Its HeritageMILWAUKEE, April 9, 2026 /PRNewswire/ -- Harley-Davidson (NYSE:HOG) reignites the brand with the global launch of RIDE, a refreshed brand platform that honors more than a century of driving motorcycle culture, designed for the riders of today, and paves a path forward for Harley-Davidson.   More than a word, RIDE is, at its core, the very idea that defines and drives Harley-Davidson. It is an action, a feeling, and a way of life that has been embedded into the brand since its foun

    4/9/26 11:00:00 AM ET
    $HOG
    Motor Vehicles
    Consumer Discretionary

    Cisco Appoints Pete Shimer to its Board of Directors

    News Summary:Cisco appoints Pete Shimer, former Deloitte executive and seasoned board leader, to its board of directors, effective today.Shimer brings four decades of executive leadership experience, including extensive C-suite tenure, and will serve on the Board's Audit Committee.His expertise in enterprise transformation, strategic planning and digital innovation are especially relevant today as Cisco delivers critical infrastructure for the AI era.SAN JOSE, Calif., April 6, 2026 /PRNewswire/ -- Cisco (NASDAQ:CSCO) today announced the appointment of Pete Shimer to its board of directors, effective immediately.

    4/6/26 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $ACRX
    $AFI
    $APCX
    $AUUD
    Financials

    Live finance-specific insights

    View All

    UNDER ARMOUR ANNOUNCES DATE FOR FOURTH QUARTER AND FULL-YEAR FISCAL 2026 EARNINGS CONFERENCE CALL

    BALTIMORE, April 23, 2026 /PRNewswire/ -- Under Armour, Inc. (NYSE:UA, UAA)) today announced that it will release its fourth quarter and full-year fiscal 2026 financial results, for the period ended March 31, 2026, on May 12, 2026. Following the earnings release, which will be issued at approximately 6:55 a.m. Eastern Time (ET), Under Armour management will host a conference call at approximately 8:30 a.m. ET to discuss the company's results.The conference call will be webcast live and available for replay on Under Armour's Investor Relations website at: https://about.underarmou

    4/23/26 4:30:00 PM ET
    $UA
    $UAA
    Apparel
    Consumer Discretionary

    Eos Energy Enterprises Announces Date for First Quarter 2026 Financial Results and Conference Call; Announces Participation at Upcoming Investor Conferences

    EDISON, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company"), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced it will release its first quarter 2026 financial results before the U.S. market opens on May 13, 2026. A conference call to discuss its results will take place the same morning at 8:30 a.m. Eastern Time. Eos partners with Say Technologies to allow retail and institutional shareholders to submit and vote on questions ahead of the earnings call. A selection of key question

    4/23/26 4:30:00 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    IREN to Release Q3 FY26 Results on May 7, 2026

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ:IREN) ("IREN") today announced that it will release its financial results for the three months ended March 31, 2026, on Thursday, May 7, 2026 and host a conference call beginning at 5:00 p.m. Eastern Time. The webcast will be recorded, and the replay will be accessible shortly after the event at https://iren.com/investor/events-and-presentations Webcast and Conference Call DetailsTime & Date:5:00 p.m. Eastern Time, Thursday, May 7, 2026 ParticipantRegistration Link Live WebcastUse this link Phone Dial-In with Live Q&AUse this link    Participants joining the conference call via the phone dial-in option will receive their di

    4/23/26 4:00:43 PM ET
    $IREN
    EDP Services
    Technology

    $ACRX
    $AFI
    $APCX
    $AUUD
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRX
    $AFI
    $APCX
    $AUUD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Indaptus Therapeutics Inc.

    SC 13D/A - Indaptus Therapeutics, Inc. (0001857044) (Subject)

    11/26/24 4:11:08 PM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by NeuroOne Medical Technologies Corporation

    SC 13G/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)

    11/26/24 8:42:10 AM ET
    $NMTC
    Medical/Dental Instruments
    Health Care